Psychopharmacology

, Volume 171, Issue 1, pp 75–80 | Cite as

Early intervention in schizophrenia: three frameworks for guiding ethical inquiry

Review

Abstract

Psychiatric research is making important strides toward early detection and treatment of schizophrenia. Discovery of genetic markers, identifiable prodromes, and low-risk interventions fuel this vital scientific movement. At the same time, investigators and clinicians are studying the ethical questions that arise whenever the bounds of diagnosis and treatment are evolving rapidly. This ethical analysis generally falls within three dominant frameworks of bioethics: the conceptualization of disease, scientific uncertainty, and risk-factor ethics. These frameworks are explored as potential guides for directing ethical inquiry in early intervention.

Keywords

Bioethics Intervention Genetic markers Risk factors 

Notes

Acknowledgements

The author's work in research ethics is supported by an NIH Career Development Award (NIH K01MH01850). The opinions expressed do not necessarily reflect those of the NIH.

References

  1. Appelbaum PS, Grisso T (1995) The MacArthur Treatment Competence Study I: mental illness and competence to consent to treatment. Law Hum Behav 19:105–126PubMedGoogle Scholar
  2. Beresford EB (1991) Uncertainty and the shaping of medical decisions, Hastings Center Report, July–August, pp 6–11Google Scholar
  3. Brett AS (1984) Ethical issues in risk factor intervention. Am J Med 78:557–561Google Scholar
  4. Drane JF (1984) Competency to give informed consent: a model for making clinical assessments. JAMA 252:925–927PubMedGoogle Scholar
  5. Dyer AR (1988) Ethics and psychiatry: toward professional definition. American Psychiatric Press, Washington D.C., Introduction, Chapter 1Google Scholar
  6. Friedman RC, Downey JI (1997) De-diseasing homosexuality. In: Edwards RB (ed) Ethics of psychiatry. Prometheus Books, Amherst, N.Y., pp 136–155Google Scholar
  7. Grisso T, Appelbaum PS (1995) The MacArthur Treatment Competence Study III: abilities of patients to consent to psychiatric and medical treatments. Law Hum Behav 19:149–174PubMedGoogle Scholar
  8. Grisso T, Appelbaum PS, Mulvey E, Fletcher K (1995) The MacArthur Treatment Competence Study II: measure of abilities related to competence to consent to treatment. Law Hum Behav 19:127–148PubMedGoogle Scholar
  9. Heinssen RK, Perkins DO, Appelbaum PS, Fenton WS (2001) Informed consent in early psychosis research. National Institute of Mental Health Workshop, November 15, 2000. Schizophr Bull 27:571–584PubMedGoogle Scholar
  10. King LS (1982) Medical thinking: a historical preface. Princeton University Press, Princeton N.J., p 139Google Scholar
  11. Layson RT, Adelman HM, Wallach PM, Pfeifer MP, Johnston S, McNutt RA, the End of Life Study Group (1994) Discussions about the use of life-sustaining treatments: a literature review of physicians' attitudes and practices. J Clin Ethics 5:195–203PubMedGoogle Scholar
  12. McGlashan TH (1999) Duration of untreated psychosis: marker or determinant of course? Biol Psychiatry 46:899–907CrossRefPubMedGoogle Scholar
  13. McGlashan TH, Johannesen JO (1996) Early detection and intervention with schizophrenia: rationale. Schizophr Bull 22:201–222PubMedGoogle Scholar
  14. McGlashan TH, Miller TJ, Woods SW (2000) Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull 27:563–570Google Scholar
  15. McGorry PD, Phillips LJ, Yung AR, Yuen HP (2001a) Predictors of psychosis: identifying young people at risk. Schizophr Res 49:6Google Scholar
  16. McGorry PD, Yung A, Phillips L (2001b) Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res 51:17–29CrossRefPubMedGoogle Scholar
  17. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, Hoffman R, Davidson L (1999) Symptom assessment in schizophrenic prodromal states. Psychiatr Q 70:273–287PubMedGoogle Scholar
  18. Murray E, Davis H, Tai SS, Coulter A, Gray A, Haines A (2001) A randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care. BMJ 323:490–493CrossRefPubMedGoogle Scholar
  19. Ritchie J, Sklar R, Steiner W (1998) Advance directives in psychiatry. Int J Law Psychiatry 21:245–260CrossRefPubMedGoogle Scholar
  20. Roberts LW, Warner TD, Brody JL (2000) Perpectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation. Am J Psychiatry 157:67–74PubMedGoogle Scholar
  21. Roberts LW, Warner TD, Brody JL, Roberts B, Lauriello JL, Lyketsos C (2002) Patient and psychiatrist ratings of hypothetical schizophrenia research protocols with assessment of harm potential and factors influencing participation decisions. Am J Psychiatry 159:573–584PubMedGoogle Scholar
  22. Roth LH, Meisel A, Lidz CW (1977) Tests of competency to consent to treatment. Am J Psychiatry 134:285–289PubMedGoogle Scholar
  23. Schaffner KF, McGorry PD (2001) Preventing severe mental illness: new prospects and ethical challenges. Schizophr Res 51:3–15CrossRefPubMedGoogle Scholar
  24. Sepucha KR, Belkora JK, Tripathy D, Esserman LJ (2000) Building bridges between physicians and patients: results of a pilot study examining new tools for collaborative decision-making in breast cancer. J Clin Oncol 18:1230–1238PubMedGoogle Scholar
  25. Stanley B, Stanley M, Peaselow E, Wolkin A, Deutsch S, Platt L, Speicher J, Golash L, Kaufman M (1982) The effects of psychotropic drugs on informed consent. Psychopharmacol Bull 18:102–104Google Scholar
  26. Stanley B, Stanley M, Lautin A, Kane J, Schwartz N (1981) Preliminary findings on psychiatric patients as research participants: a population at risk? Am J Psychiatry 138:669–671PubMedGoogle Scholar
  27. Warner R (2000) The prevention of schizophrenia: what interventions are safe and effective? Schizophr Bull 27:551–562Google Scholar
  28. Wyatt RJ (1991) Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17:325–351PubMedGoogle Scholar
  29. Wyatt RJ, Henter I (2001) Rationale for the study of early intervention. Schizophr Res 51:69–76CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  1. 1.Department of PsychiatryUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations